Loading insider details...
Beta
Latest Form 4 (Jan 6, 2026): Grant/Award of 2,600 RNAC shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jan 6, 2026 | Cartesian Therapeutics, Inc. (RNAC) | Grant/Award | 2,600 | n/a |
| Jan 6, 2025 | Cartesian Therapeutics, Inc. (RNAC) | Grant/Award | 2,600 | n/a |
| Jan 4, 2024 | Cartesian Therapeutics, Inc. (RNAC) | Grant/Award | 178,000 | n/a |
| Nov 15, 2023 | Cartesian Therapeutics, Inc. (RNAC) | Disposition to Issuer | 80,000 | n/a |
| Jan 4, 2023 | SELECTA BIOSCIENCES INC (SELB) | Grant/Award | 75,000 | n/a |
| Jan 5, 2022 | SELECTA BIOSCIENCES INC (SELB) | Grant/Award | 40,000 | n/a |
| Dec 6, 2021 | SELECTA BIOSCIENCES INC (SELB) | Purchase | 7,000 | $20.7K |
| Jul 9, 2021 | SELECTA BIOSCIENCES INC (SELB) | Grant/Award | 80,000 | n/a |